Trial Outcomes & Findings for Clinical Comparison of Two Daily Disposable Contact Lenses (NCT NCT04865354)
NCT ID: NCT04865354
Last Updated: 2022-07-06
Results Overview
Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.
COMPLETED
NA
170 participants
Day 8, each study lens type
2022-07-06
Participant Flow
This study was conducted at 8 investigative sites in the United States.
Of the 170 enrolled, 3 subjects were exited prior to randomization as screen failures. This reporting group includes all randomized subjects (167).
Participant milestones
| Measure |
PRECISION1, Then Clariti 1-Day
Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
|
Clariti 1-Day, Then PRECISION1
Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
|
|---|---|---|
|
First Wear Period (8 Days)
STARTED
|
83
|
84
|
|
First Wear Period (8 Days)
COMPLETED
|
82
|
83
|
|
First Wear Period (8 Days)
NOT COMPLETED
|
1
|
1
|
|
Second Wear Period (8 Days)
STARTED
|
82
|
83
|
|
Second Wear Period (8 Days)
COMPLETED
|
81
|
83
|
|
Second Wear Period (8 Days)
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
| Measure |
PRECISION1, Then Clariti 1-Day
Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
|
Clariti 1-Day, Then PRECISION1
Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
|
|---|---|---|
|
First Wear Period (8 Days)
Withdrawal by Subject
|
1
|
0
|
|
First Wear Period (8 Days)
Lost to Follow-up
|
0
|
1
|
|
Second Wear Period (8 Days)
Protocol deviation, dispensed wrong powers
|
1
|
0
|
Baseline Characteristics
Clinical Comparison of Two Daily Disposable Contact Lenses
Baseline characteristics by cohort
| Measure |
PRECISION1, Then Clariti 1-Day
n=83 Participants
Verofilcon A contact lenses worn first, with somofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
|
Clariti 1-Day, Then PRECISION1
n=84 Participants
Somofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for 8 days in a daily disposable modality.
|
Total
n=167 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
31.3 years
STANDARD_DEVIATION 8.9 • n=5 Participants
|
31.4 years
STANDARD_DEVIATION 7.5 • n=7 Participants
|
31.4 years
STANDARD_DEVIATION 8.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
54 Participants
n=5 Participants
|
62 Participants
n=7 Participants
|
116 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
29 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
78 Participants
n=5 Participants
|
76 Participants
n=7 Participants
|
154 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
69 Participants
n=5 Participants
|
67 Participants
n=7 Participants
|
136 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
1 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
12 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
25 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
83 participants
n=5 Participants
|
84 participants
n=7 Participants
|
167 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day 8, each study lens typePopulation: Full Analysis Set: All randomized subjects who are exposed to any study lenses evaluated in this study with non-missing response (eye)
Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal visual acuity), with a negative value denoting better than 20/20 visual acuity.
Outcome measures
| Measure |
PRECISION1
n=328 eyes
Verofilcon A contact lenses worn bilaterally (in both eyes) during Period 1 or Period 2, as randomized, for 8 days in a daily disposable modality
|
Clariti 1-Day
n=164 Participants
Somofilcon A contact lenses worn bilaterally (in both eyes) during Period 1 or Period 2, as randomized, for 8 days in a daily disposable modality
|
|---|---|---|
|
Least Squares Mean Distance VA (logMAR) With Study Lenses
|
-0.119 logMAR
Standard Error 0.0055
|
-0.122 logMAR
Standard Error 0.0055
|
Adverse Events
Pretreatment
PRECISION1 Ocular
PRECISION1 Systemic
Clariti 1-Day Ocular
Clariti 1-Day Systemic
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Sr. Project Lead, CDMA Vision Care
Alcon Research, LLC
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER